Spain’s Public Health Commission meets this Tuesday, 7 December, bringing together experts from the Ministry of Health and the autonomous regions to decide how the coronavirus vaccination strategy is going to be carried out in children between 5 and 11 years old.
After the approval of the European Medicines Agency (EMA) to extend the current European license of the pharmaceutical companies Pfizer and BioNTech to use the vaccine in children of that age, the commission will have to decide how, when and where the vaccinations will be carried out.
In Spain, more than 3 million children could receive Pfizer's formula, which will be a third of the dose used for adults. In this age group, the vaccine is planned to be administered in two doses, three weeks apart.
The Minister of Health, Carolina Darias, recently indicated that the vaccine is not the same as that used in adults because "it does not need diluting" and the amount is "less" and "different".
More to follow…